State Street’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

State Street’s Portfolio ENZN Stock Details ENZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-28,090	Closed	-$13K	–	3845
2016 Q1	$13K	Hold	28,090	–	–	﹤0.01%	3688
2015 Q4	$19K	Hold	28,090	–	–	﹤0.01%	3663
2015 Q3	$27K	Hold	28,090	–	–	﹤0.01%	3633
2015 Q2	$33K	Hold	28,090	–	–	﹤0.01%	3630
2015 Q1	$30K	Sell	28,090 -4,285	-13%	-$4.43K	﹤0.01%	3614
2014 Q4	$36K	Sell	32,375 -2,400	-7%	-$2.52K	﹤0.01%	3613
2014 Q3	$38K	Sell	34,775 -1,500	-4%	-$1.85K	﹤0.01%	3603
2014 Q2	$38K	Sell	36,275 -1,378,331	-97%	-$1.31M	﹤0.01%	3569
2014 Q1	$1.46M	Buy	1,414,606 +111,479	+9%	+$115K	﹤0.01%	3172
2013 Q4	$1.51M	Buy	1,303,127 +154,657	+13%	+$238K	﹤0.01%	3167
2013 Q3	$1.93M	Sell	1,148,470 -85,699	-7%	-$159K	﹤0.01%	3057
2013 Q2	$2.47M	Buy	+1,234,169	New	+$3.61M	﹤0.01%	2865

Other funds holding ENZN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

OSAM

O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

MCM

Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return

CFA

CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

State Street's ENZN Position: Q2 2016 in Review

State Street sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 28,090 shares — an estimated $13K sold.

State Street first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $2.47M in Q2 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

State Street reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
State Street sold 28,090 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $13K.
State Street first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 12 quarters.
State Street's ENZON PHARMACEUTICALS INC position peaked at $2.47M in Q2 2013.
10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on State Street's 13F filing for Q2 2016, filed 12 Aug 2016.